Publication | Closed Access
A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males
22
Citations
4
References
2019
Year
Clinical TranslationMedicineReference ProductHealthy Adult MalesPharmacologyTherapeutic EfficacyPharmacotherapyOncologyCandidate Bevacizumab Biosimilar
| Year | Citations | |
|---|---|---|
Page 1
Page 1